In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

Researchers reported a spine-stimulating implant might aid neurodegenerative diseases like spinal muscle atrophy.

The first-in-human trial saw all three patients able to increase their walking distance within six minutes to 20 meters.

Learn more about whether Bausch + Lomb Corporation or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Aidan Hutchinson could still play in Super Bowl 2025 if Lions make it, a panel of doctors agree, despite broken leg injury ...

Cameras caught the excruciating moment when Hutchinson's lower leg snapped after it slammed ... also to prevent atrophy. For some of the higher-level pro athletes ... there's another device ...

Patients commonly present with muscle cramps, tremors, leg weakness ... features of SBMA with asymmetric atrophy and weakness of the proximal limb and bulbar muscles, as well as hand tremor consistent ...

Background: Multiple system atrophy-cerebellar subtype (MSA-C ... accompanied by weakness of both lower limbs, which manifested as shuffling walking, difficulty in lifting the legs, and falling easily ...